U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.1372_1373del (p.Lys458fs) AND Monogenic diabetes

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 1, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003325946.2

Allele description [Variation Report for NM_000162.5(GCK):c.1372_1373del (p.Lys458fs)]

NM_000162.5(GCK):c.1372_1373del (p.Lys458fs)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.1372_1373del (p.Lys458fs)
Other names:
NM_000162.5(GCK):c.1372_1373del; p.Lys458fs
HGVS:
  • NC_000007.14:g.44145161_44145162del
  • NG_008847.2:g.58009_58010del
  • NM_000162.5:c.1372_1373delMANE SELECT
  • NM_001354800.1:c.1369+3_1369+4del
  • NM_001354801.1:c.361_362del
  • NM_001354802.1:c.229+3_229+4del
  • NM_001354803.2:c.406_407del
  • NM_033507.3:c.1375_1376del
  • NM_033508.3:c.1369_1370del
  • NP_000153.1:p.Lys458fs
  • NP_001341730.1:p.Lys121fs
  • NP_001341732.1:p.Lys136fs
  • NP_277042.1:p.Lys459fs
  • NP_277043.1:p.Lys457fs
  • LRG_1074t1:c.1372_1373del
  • LRG_1074t2:c.1375_1376del
  • LRG_1074:g.58009_58010del
  • LRG_1074p1:p.Lys458fs
  • LRG_1074p2:p.Lys459fs
  • NC_000007.13:g.44184760_44184761del
  • NM_000162.3:c.1372_1373delAA
  • p.Lys458GlufsX8+
Protein change:
K121fs
Links:
dbSNP: rs193922284
NCBI 1000 Genomes Browser:
rs193922284
Molecular consequence:
  • NM_000162.5:c.1372_1373del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354801.1:c.361_362del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354803.2:c.406_407del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033507.3:c.1375_1376del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033508.3:c.1369_1370del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354800.1:c.1369+3_1369+4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354802.1:c.229+3_229+4del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004032107ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Monogenic Diabetes ACMG Specifications GCK V1.3.0)
Likely pathogenic
(Sep 1, 2023)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004032107.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.1372_1373del variant in the glucokinase gene, GCK, causes a frameshift in the protein at codon 458 (NM_000162.6), adding 75 novel amino acids before encountering a stop codon (p.(Lys458GlufsTer75)). This variant, located in exon 10 of 10, is predicted to cause loss of a stop codon and result in an elongated protein. The additional residues are expected to cause improper folding, resulting in loss of function in a gene in which loss-of-function is an established disease mechanism (PVS1; PMID 19790256). Additionally, this variant is absent in gnomAD v.2.1.1 (PM2_Supporting). This variant was identified in 2 unrelated individuals with a clinical picture consistent with non-autoimmune/insulin-deficient diabetes, however PS4 cannot be applied because this number is below the MDEP threshold (internal lab contributors). This variant was identified in a case consistent with GCK-hyperglycemia but there was insufficient clinical information to evaluate for PP4 (internal lab contributors). This variant segregated with disease with one informative meiosis in a family with MODY, however this does not meet the thresholds for PP1 set by Jarvik and Browning (PMID 27236918) (internal lab contributors). In summary, c.1372_1373del meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PVS1, PM2_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2023